HDAC9 and retinoblastoma: A poor prognosis in RB patients was correlated with downregulation of miR-936, and its overexpression decreased RB aggressiveness by reducing HDAC9 mRNA and subsequently inactivating the PI3K/AKT pathway (Xu et al., 2020a).